References
- Reddy AJ, Lam SW, Bauer SR, Guzman JA. Lactic acidosis: clinical implications and management strategies. Cleve Clin J Med. 2015;82(9):615–624. doi:https://doi.org/10.3949/ccjm.82a.14098.
- Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J. 1996;9(8):1736–1742. doi:https://doi.org/10.1183/09031936.96.09081736.
- Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc. 2013;88(10):1127–1140. doi:https://doi.org/10.1016/j.mayocp.2013.06.012.
- Heiden MGV, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:https://doi.org/10.1126/science.1160809.
- Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:https://doi.org/10.1126/science.123.3191.309.
- Halestrap AP. The monocarboxylate transporter family-structure and functional characterization. IUBMB Life. 2012;64(1):1–9. doi:https://doi.org/10.1002/iub.573.
- Robb CT, Regan KH, Dorward DA, Rossi AG. Key mechanisms governing resolution of lung inflammation. Semin Immunopathol. 2016;38(4):425–448. doi:https://doi.org/10.1007/s00281-016-0560-6.
- Kruse O, Grunnet N, Barfod C. Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospital: a systematic review. Scand J Trauma Resusc Emerg Med. 2011;19:74. doi:https://doi.org/10.1186/1757-7241-19-74.
- Howell MD, Donnino M, Clardy P, Talmor D, Shapiro NI. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med. 2007;33(11):1892–1899. doi:https://doi.org/10.1007/s00134-007-0680-5.
- Arthur RE, Stern M, Galeazzi M, et al. Synovial fluid lactic acid in septic and nonseptic arthritis. Arthritis Rheum. 1983;26(12):1499–1505. doi:https://doi.org/10.1002/art.1780261212.
- Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60(4):916–921.
- Goetze K, Walenta S, Ksiazkiewicz M, Kunz-Schughart LA, Mueller-Klieser W. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol. 2011;39(2):453–463. doi:https://doi.org/10.3892/ijo.2011.1055.
- Qiqiang L, Huanxin M, Xuejun G. Longitudinal study of volatile fatty acids in the gingival crevicular fluid of patients with periodontitis before and after nonsurgical therapy. J Periodontal Res. 2012;47(6):740–749. doi:https://doi.org/10.1111/j.1600-0765.2012.01489.x.
- Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer. 2003;89(5):877–885. doi:https://doi.org/10.1038/sj.bjc.6601205.
- Shapiro NI, Howell MD, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45(5):524–528. doi:https://doi.org/10.1016/j.annemergmed.2004.12.006.
- Okorie ON, Dellinger P. Lactate: biomarker and potential therapeutic target. Crit Care Clin. 2011;27(2):299–326. doi:https://doi.org/10.1016/j.ccc.2010.12.013.
- Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. Virology. 2015;479–480:609–618. doi:https://doi.org/10.1016/j.virol.2015.02.038.
- Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36–49. doi:https://doi.org/10.1038/nri3581.
- Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15(7):405–414. doi:https://doi.org/10.1038/nri3845.
- Ren Z, Ding T, Zuo Z, Xu Z, Deng J, Wei Z. Regulation of MAVS expression and signaling function in the antiviral innate immune response. Front Immunol. 2020;11:1030. doi:https://doi.org/10.3389/fimmu.2020.01030.
- Belgnaoui SM, Paz S, Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol. 2011;23(5):564–572. doi:https://doi.org/10.1016/j.coi.2011.08.001.
- Zhang W, Wang G, Xu Z, et al. Lactate is a natural suppressor of RLR signaling by targeting MAVS. Cell. 2019;178(1):176–189.e15. doi:https://doi.org/10.1016/j.cell.2019.05.003.
- Zhou L, He R, Fang P, et al. Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition. Nat Commun. 2021;12(1):98. doi:https://doi.org/10.1038/s41467-020-20316-8.
- Desai TM, Marin M, Mason C, Melikyan GB. pH regulation in early endosomes and interferon-inducible transmembrane proteins control avian retrovirus fusion. J Biol Chem. 2017;292(19):7817–7827. doi:https://doi.org/10.1074/jbc.M117.783878.
- Scherrmann JM. Intracellular ABCB1 as a possible mechanism to explain the synergistic effect of hydroxychloroquine-azithromycin combination in COVID-19 therapy. AAPS J. 2020;22(4):86. doi:https://doi.org/10.1208/s12248-020-00465-w.
- Cure E, Cumhur Cure M. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. Diabetes Metab Syndr. 2020;14(4):405–406. doi:https://doi.org/10.1016/j.dsx.2020.04.024.
- Mair CM, Ludwig K, Herrmann A, Sieben C. Receptor binding and pH stability – how influenza A virus hemagglutinin affects host-specific virus infection. Biochim Biophys Acta. 2014;1838(4):1153–1168. https://doi.org/10.1016/j.bbamem.2013.10.004
- Chen Y, Liang W, Yang S, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013;381(9881):1916–1925. doi:https://doi.org/10.1016/S0140-6736(13)60903-4.
- Hunt L, Gupta-Wright A, Simms V, et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2015;15(11):1292–1299. doi:https://doi.org/10.1016/S1473-3099(15)00144-9.
- Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–1994. doi:https://doi.org/10.1056/NEJMoa030685.
- Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis. 2003;9(9):1064–1069. doi:https://doi.org/10.3201/eid0909.030362.
- Wong R, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ. 2003;326(7403):1358–1362. doi:https://doi.org/10.1136/bmj.326.7403.1358.
- Nicholls JM, Poon L, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361(9371):1773–1778. doi:https://doi.org/10.1016/S0140-6736(03)13413-7.
- Antonio GE, Wong KT, Hui D, et al. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology. 2003;228(3):810–815. doi:https://doi.org/10.1148/radiol.2283030726.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:https://doi.org/10.1016/S0140-6736(20)30211-7.
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:https://doi.org/10.1016/S0140-6736(20)30183-5.
- Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–374. doi:https://doi.org/10.1007/s11427-020-1643-8.
- Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi:https://doi.org/10.1016/S0140-6736(20)32656-8.
- Kottmann RM, Kulkarni AA, Smolnycki KA, et al. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Am J Respir Crit Care Med. 2012;186(8):740–751. doi:https://doi.org/10.1164/rccm.201201-0084OC.
- Liu D, Gong L, Zhu H, et al. Curcumin inhibits transforming growth factor beta induced differentiation of mouse lung fibroblasts to myofibroblasts. Front Pharmacol. 2016;7:419. doi:https://doi.org/10.3389/fphar.2016.00419.
- Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997;100(4):768–776. doi:https://doi.org/10.1172/JCI119590.
- Judge JL, Nagel DJ, Owens KM, et al. Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol. PLoS One. 2018;13(5):e0197936. doi:https://doi.org/10.1371/journal.pone.0197936.
- Judge JL, Lacy SH, Ku W, et al. The lactate dehydrogenase inhibitor gossypol inhibits radiation-induced pulmonary fibrosis. Radiat Res. 2017;188(1):35–43. doi:https://doi.org/10.1667/RR14620.1.
- Wagner W, Ciszewski W, Kania K, Dastych J. Lactate stimulates IL-4 and IL-13 production in activated HuT-78 T lymphocytes through a process that involves monocarboxylate transporters and protein hyperacetylation. J Interferon Cytokine Res. 2016;36(5):317–327. doi:https://doi.org/10.1089/jir.2015.0086.
- Liu Y, Munker S, Müllenbach R, Weng H-L. IL-13 signaling in liver fibrogenesis. Front Immunol. 2012;3(116):116. doi:https://doi.org/10.3389/fimmu.2012.00116.
- Rankin JA, Picarella DE, Geba GP, et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci U S A. 1996;93(15):7821–7825. doi:https://doi.org/10.1073/pnas.93.15.7821.
- Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999;103(6):779–788. doi:https://doi.org/10.1172/JCI5909.
- Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011;208(7):1339–1350. doi:https://doi.org/10.1084/jem.20110551.
- George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815. doi:https://doi.org/10.1016/S2213-2600(20)30225-3.
- Tang S, Wan M, Huang W, Stanton RC, Xu Y. Maresins: specialized proresolving lipid mediators and their potential role in inflammatory-related diseases. Mediators Inflamm. 2018;2018:2380319. doi:https://doi.org/10.1155/2018/2380319.
- Dalli J, Serhan CN. Pro-resolving mediators in regulating and conferring macrophage function. Front Immunol. 2017;8:1400. doi:https://doi.org/10.3389/fimmu.2017.01400.
- Serhan CN, Dalli J, Colas RA, Winkler JW, Chiang N. Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim Biophys Acta. 2015;1851(4):397–413. doi:https://doi.org/10.1016/j.bbalip.2014.08.006.
- Abebayehu D, Spence AJ, Qayum AA, et al. Lactic acid suppresses IL-33-mediated mast cell inflammatory responses via hypoxia-inducible factor-1α-dependent miR-155 suppression. J Immunol. 2016;197(7):2909–2917. doi:https://doi.org/10.4049/jimmunol.1600651.
- Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol. 2011;12(11):1035–1044. doi:https://doi.org/10.1038/ni.2109.
- Amin K. The role of mast cells in allergic inflammation. Respir Med. 2012;106(1):9–14. doi:https://doi.org/10.1016/j.rmed.2011.09.007.
- Abebayehu D, Spence AJ, Caslin H, et al. Lactic acid suppresses IgE-mediated mast cell function in vitro and in vivo. Cell Immunol. 2019;341:103918. doi:https://doi.org/10.1016/j.cellimm.2019.04.006.
- Hoque R, Farooq A, Ghani A, Gorelick F, Mehal WZ. Lactate reduces liver and pancreatic injury in toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology. 2014;146(7):1763–1774. doi:https://doi.org/10.1053/j.gastro.2014.03.014.
- Iraporda C, Romanin DE, Bengoa AA, et al. Local treatment with lactate prevents intestinal inflammation in the TNBS-induced colitis model. Front Immunol. 2016;7:651. doi:https://doi.org/10.3389/fimmu.2016.00651.
- Madaan A, Nadeau-Vallee M, Rivera JC, et al. Lactate produced during labor modulates uterine inflammation via GPR81 (HCA1). Am J Obstet Gynecol. 2017;216(1):60.e1–60.e17. doi:https://doi.org/10.1016/j.ajog.2016.09.072.
- O’Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One. 2013;8(11):e80074. https://doi.org/10.1371/journal.pone.0080074
- Errea A, Cayet D, Marchetti P, et al. Lactate inhibits the pro-inflammatory response and metabolic reprogramming in murine macrophages in a GPR81-independent manner. PLoS One. 2016;11(11):e0163694. doi:https://doi.org/10.1371/journal.pone.0163694.
- Tyssen D, Wang YY, Hayward JA, et al. Anti-HIV-1 activity of lactic acid in human cervicovaginal fluid. mSphere. 2018;3(4):e00055–18. doi:https://doi.org/10.1128/mSphere.00055-18.
- Witkin SS. Lactic acid alleviates stress: good for female genital tract homeostasis, bad for protection against malignancy. Cell Stress Chaperones. 2018;23(3):297–302. doi:https://doi.org/10.1007/s12192-017-0852-3.
- Rajendran P, Chen Y, Chen Y, et al. The multifaceted link between inflammation and human diseases. J Cell Physiol. 2018;233(9):6458–6471. doi:https://doi.org/10.1002/jcp.26479.
- Haas R, Smith J, Rocher-Ros V, et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 2015;13(7):e1002202. doi:https://doi.org/10.1371/journal.pbio.1002202.
- Pucino V, Certo M, Bulusu V, et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4+ T cell metabolic rewiring. Cell Metab. 2019;30(6):1055–1074.e8. doi:https://doi.org/10.1016/j.cmet.2019.10.004.
- Yang XY, Zheng KD, Lin K, et al. Energy metabolism disorder as a contributing factor of rheumatoid arthritis: a comparative proteomic and metabolomic study. PLoS One. 2015;10(7):e0132695. doi:https://doi.org/10.1371/journal.pone.0132695.
- Li C, Chen B, Fang Z, et al. Metabolomics in the development and progression of rheumatoid arthritis: a systematic review. Joint Bone Spine. 2020;87(5):425–430. https://doi.org/10.1016/j.jbspin.2020.05.005
- Gerriets VA, Rathmell JC. Metabolic pathways in T cell fate and function. Trends Immunol. 2012;33(4):168–173. doi:https://doi.org/10.1016/j.it.2012.01.010.
- Haas R, Marelli-Berg F, Mauro C. In the eye of the storm: T cell behavior in the inflammatory microenvironment. Am J Clin Exp Immunol. 2013;2(2):146–155.
- Koss MA, Castro CE, Salum KM, Lopez ME. Enzymatic profile of gingival crevicular fluid in association with periodontal status. Lab Med. 2009;40(5):277–280. doi:https://doi.org/10.1309/LMCNUQI8ULCUK2BK.
- Berglundh T, Donati M. Aspects of adaptive host response in periodontitis. J Clin Periodontol. 2005;32 Suppl 6:87–107. doi:https://doi.org/10.1111/j.1600-051X.2005.00820.x.
- Berglundh T, Liljenberg B, Lindhe J. Some effects of periodontal therapy on local and systemic immunological parameters. J Clin Periodontol. 1999;26(2):91–98. doi:https://doi.org/10.1034/j.1600-051x.1999.260205.x.
- Zhao L, Zhou Y, Xu Y, Sun Y, Li L, Chen W. Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients. J Clin Periodontol. 2011;38(6):509–516. doi:https://doi.org/10.1111/j.1600-051X.2011.01712.x.
- Cheng W, Hughes FJ, Taams LS. The presence, function and regulation of IL-17 and Th17 cells in periodontitis. J Clin Periodontol. 2014;41(6):541–549. doi:https://doi.org/10.1111/jcpe.12238.
- Bunte K, Beikler T. Th17 cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases. Int J Mol Sci. 2019;20:3394. doi:https://doi.org/10.3390/ijms20143394.
- Xiao E, Mattos M, Apolinario Vieira GH, et al. Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity. Cell Host Microbe. 2017;22(1):120–128.e4. doi:https://doi.org/10.1016/j.chom.2017.06.014.
- Kampylafka E, D’Oliveira I, Linz C, et al. Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study. Arthritis Res Ther. 2018;20(1):153. doi:https://doi.org/10.1186/s13075-018-1653-5.
- Blanco FJ, Möricke R, Dokoupilova E, et al. Secukinumab in active rheumatoid arthritis: a phase III randomized, double-blind, active comparator- and placebo-controlled study. Arthritis Rheumatol. 2017;69(6):1144–1153. doi:https://doi.org/10.1002/art.40070.
- Souto-Carneiro MM, Klika KD, Abreu MT, et al. Effect of increased lactate dehydrogenase A activity and aerobic glycolysis on the proinflammatory profile of autoimmune CD8+ T cells in rheumatoid arthritis. Arthritis Rheumatol. 2020;72(12):2050–2064. doi:https://doi.org/10.1002/art.41420.
- Gotmaker R, Peake SL, Forbes A, Bellomo R. ARISE investigators* (2017) mortality is greater in septic patients with hyperlactatemia than with refractory hypotension. Shock. 2017;48(3):294–300. doi:https://doi.org/10.1097/SHK.0000000000000861.
- Zhou X, Liu D, Su L, et al. Use of stepwise lactate kinetics-oriented hemodynamic therapy could improve the clinical outcomes of patients with sepsis-associated hyperlactatemia. Crit Care. 2017;21(1):33. doi:https://doi.org/10.1186/s13054-017-1617-1.
- Noormandi A, Khalili H, Mohammadi M, Abdollahi A. Effect of magnesium supplementation on lactate clearance in critically ill patients with severe sepsis: a randomized clinical trial. Eur J Clin Pharmacol. 2020;76(2):175–184. doi:https://doi.org/10.1007/s00228-019-02788-w.
- Zhu Y, Han XQ, Sun XJ, Yang R, Ma WQ, Liu NF. Lactate accelerates vascular calcification through NR4A1-regulated mitochondrial fission and BNIP3-related mitophagy. Apoptosis. 2020;25(5–6):321–340. https://doi.org/10.1007/s10495-020-01592-7
- Valiente-Pallejà A, Torrell H, Alonso Y, Vilella E, Muntané G, Martorell L. Increased blood lactate levels during exercise and mitochondrial DNA alterations converge on mitochondrial dysfunction in schizophrenia. Schizophr Res. 2020;220:61–68. https://doi.org/10.1016/j.schres.2020.03.070
- Ayala JC, Grismaldo A, Aristizabal-Pachon AF, et al. Mitochondrial dysfunction in intensive care unit patients. Curr Pharm Des. 2020;27:3074–3081. https://doi.org/10.2174/1381612826666201207112931.
- Xu J, Ma X, Yu K, et al. Lactate up-regulates the expression of PD-L1 in kidney and causes immunosuppression in septic acute renal injury. J Microbiol Immunol Infect. 2019;1182:30168–30169. doi:https://doi.org/10.1016/j.jmii.2019.10.006.
- Caslin HL, Abebayehu D, Qayum AA, et al. Lactic acid inhibits lipopolysaccharide-induced mast cell function by limiting glycolysis and ATP availability. J Immunol. 2019;203(2):453–464. doi:https://doi.org/10.4049/jimmunol.1801005.
- Lewis DH, Chan DL, Pinheiro D, Armitage-Chan E, Garden OA. The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells. J Vet Intern Med. 2012;26(3):457–482. doi:https://doi.org/10.1111/j.1939-1676.2012.00905.x.
- Boomer JS, To K, Chang KC, Takasu O, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594–2605. doi:https://doi.org/10.1001/jama.2011.1829.
- Delano MJ, Ward PA. The immune system’s role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016;274(1):330–353. doi:https://doi.org/10.1111/imr.12499.
- Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1–10. doi:https://doi.org/10.1016/j.immuni.2013.07.012.
- Huber V, Camisaschi C, Berzi A, et al. Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol. 2017;43:74–89. doi:https://doi.org/10.1016/j.semcancer.2017.03.001.
- Colegio OR, Ngoc-Quynh C, Szabo AL, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513(7519):559–563. doi:https://doi.org/10.1038/nature13490.
- Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575–580. doi:https://doi.org/10.1038/s41586-019-1678-1.
- Galvan-Pena S, O’Neill LAJ. Metabolic reprograming in macropage polarization. Front Immunol. 2014;5:420. doi:https://doi.org/10.3389/fimmu.2014.00420.
- Dietl K, Renner K, Dettmer K, et al. Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. JI. 2010;184(3):1200–1209. doi:https://doi.org/10.4049/jimmunol.0902584.
- Peter K, Rehli M, Singer K, Renner-Sattler K, Kreutz M. Lactic acid delays the inflammatory response of human monocytes. Biochem Biophys Res Commun. 2015;457(3):412–418. doi:https://doi.org/10.1016/j.bbrc.2015.01.005.
- Shime H, Yabu M, Akazawa T, et al. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J Immunol. 2008;180(11):7175–7183. doi:https://doi.org/10.4049/jimmunol.180.11.7175.
- Brown TP, Bhattacharjee P, Ramachandran S, et al. The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment. Oncogene. 2020;39(16):3292–3304. doi:https://doi.org/10.1038/s41388-020-1216-5.
- Feng J, Yang H, Zhang Y, et al. Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. Oncogene. 2017;36(42):5829–5839. doi:https://doi.org/10.1038/onc.2017.188.
- Pauken KE, Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 2015;36(4):265–276. doi:https://doi.org/10.1016/j.it.2015.02.008.
- Brand A, Singer K, Koehl GE, et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 2016;24(5):657–671. doi:https://doi.org/10.1016/j.cmet.2016.08.011.
- Harmon C, Robinson MW, Hand F, et al. Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis. Cancer Immunol Res. 2019;7(2):335–346. doi:https://doi.org/10.1158/2326-6066.CIR-18-0481.
- Pilon-Thomas S, Kodumudi KN, El-Kenawi AE, et al. Neutralization of tumor acidity improves antitumor responses to immunotherapy. Cancer Res. 2016;76(6):1381–1390. doi:https://doi.org/10.1158/0008-5472.CAN-15-1743.
- Greten TF, Manns MP, Korangy F. Myeloid derived suppressor cells in human diseases. Int Immunopharmacol. 2011;11(7):802–807. doi:https://doi.org/10.1016/j.intimp.2011.01.003.
- Husain Z, Huang Y, Seth P, Sukhatme VP. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol. 2013;191(3):1486–1495. doi:https://doi.org/10.4049/jimmunol.1202702.
- Comito G, Iscaro A, Bacci M, et al. Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis. Oncogene. 2019;38(19):3681–3695. doi:https://doi.org/10.1038/s41388-019-0688-7.
- Rothberg JM, Bailey KM, Wojtkowiak JW, et al. Acid-mediated tumor proteolysis: contribution of cysteine cathepsins. Neoplasia. 2013;15(10):1125–1137. doi:https://doi.org/10.1593/neo.13946.
- Rothberg JM, Sameni M, Moin K, Sloane BF. Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment. Biochim Biophys Acta. 2012;1824(1):123–132. doi:https://doi.org/10.1016/j.bbapap.2011.07.025.
- Komoll RM, Hu Q, Olarewaju O, et al. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma. J Hepatol. 2021;74(1):122–134. https://doi.org/10.1016/j.jhep.2020.07.039
- Ahmed K, Tunaru S, Offermanns S. GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol Sci. 2009;30(11):557–562. https://doi.org/10.1016/j.tips.2009.09.001
- Payen VL, Mina E, Van Hée VF, Porporato PE, Sonveaux P. Monocarboxylate transporters in cancer. Mol Metab. 2020;33:48–66. https://doi.org/10.1016/j.molmet.2019.07.006